Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 217

recruiting
3 974
countries
28
conditions
2 109

10 386 trials match your criteria

Study on the Safety and Effectiveness of Botulinum Toxin A for Patients with Persistent Post-Traumatic Headache

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Study on the Effects of Etidronate on Brain Calcification in Patients with Fahr's Disease

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Flunarizine hydrochloride

Hypoxia+2

Recruiting

Oxygen Therapy to Prevent Breathing Problems After Non-Cardiac Surgery in Patients at Risk for Postoperative Complications

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:65+ years

Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Predominant Irritable Bowel Syndrome

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Study on the Safety of Inhaled Teicoplanin for Treating Staphylococcus aureus Infections in Cystic Fibrosis Patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
Countries:ItalyItaly
  • Participants:18–64 years

Study on Ruxolitinib and Methoxsalen for Patients with Steroid-Refractory Chronic Graft-versus-Host Disease

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.